Omnicuris Logo
Cetoleic Acid: A Novel Fish Oil Component for LDL-Cholesterol Reduction?

Cetoleic Acid: A Novel Fish Oil Component for LDL-Cholesterol Reduction?

Read More
Full Text
2 weeks back

Introduction: Beyond Standard Omega-3s


Cardiovascular disease (CVD) remains a primary global health concern, with elevated LDL-cholesterol serving as a critical risk factor. While marine fish consumption is traditionally linked to better heart health, standard omega-3 fatty acids like EPA and DHA often fail to significantly lower cholesterol levels. However, recent research into cetoleic acid LDL reduction suggests that other components of fish oil might offer potent lipid-lowering benefits. Cetoleic acid (CA), a long-chain monounsaturated fatty acid found in species like herring, is now emerging as a promising candidate for metabolic health intervention.



The Clinical Trial: Cetoleic Acid vs. Standard Care


A recent randomised, double-blind controlled clinical trial investigated the impact of CA on 80 adults with overweight or obesity. Researchers divided participants into two specific groups for an eight-week intervention. The first group received a cetoleic acid concentrate (CECO), providing 1480 mg of CA daily. In contrast, the comparator group (SOYO3) received soybean oil mixed with a standard omega-3 concentrate. Consequently, this design allowed investigators to isolate the effects of CA from traditional polyunsaturated fatty acids.



Significant Results in Lipid Management


The study findings revealed a meaningful shift in lipid profiles. Specifically, the group receiving the cetoleic acid concentrate saw a statistically significant reduction in LDL-cholesterol compared to the control group. Data analysis showed a relative reduction of approximately 7% in the CECO group (P=0.033). Furthermore, the researchers utilized ANCOVA with body fat percentage as a covariate to ensure the results were specifically due to the fatty acid intake rather than weight fluctuations. Therefore, these results suggest that cetoleic acid LDL reduction is a distinct physiological effect of this omega-11 fatty acid.



Mechanisms and Clinical Relevance


Earlier rodent studies hinted at this potential, showing lower LDL concentrations after CA intake. Unlike EPA and DHA, which primarily target triglycerides, CA appears to influence cholesterol metabolism directly. Additionally, some evidence suggests CA might enhance the body's internal conversion of alpha-linolenic acid into EPA/DHA, though the cholesterol-lowering effect seems independent of this pathway. For clinicians in India, where dyslipidemia is prevalent among overweight populations, this fatty acid represents a potential new tool in the nutraceutical arsenal for cardiovascular risk management.



FAQ: Understanding Cetoleic Acid


What is cetoleic acid?


Cetoleic acid, also known as omega-11, is a long-chain monounsaturated fatty acid found in high concentrations in North Atlantic pelagic fish like herring and mackerel.



How does it differ from standard fish oil supplements?


Most fish oils focus on EPA and DHA, which are effective at lowering triglycerides but have a negligible effect on LDL-cholesterol. Cetoleic acid specifically demonstrates an ability to reduce LDL levels.



Can this replace statins for cholesterol management?


No, cetoleic acid is currently viewed as a dietary supplement or functional food ingredient. It should be used as part of a comprehensive lifestyle or therapeutic plan under medical supervision.



Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.



References


Hansen K et al. Supplementation with a cetoleic acid concentrate decreased the serum LDL-cholesterol concentration in healthy adults with overweight or obesity. A randomised double-blind controlled clinical trial. Br J Nutr. 2026 May 06. doi: 10.1017/S0007114526107375. PMID: 42087284.


Nundal C, et al. Fish oils rich in omega-11 (cetoleic acid) may significantly reduce cholesterol and triglyceride levels. Frontiers in Nutrition. 2024.


Wakeman M, et al. CETO3 omega-11 raises omega-3 index more efficiently than standard fish oil. University of Sunderland Research Repository. 2024.

Login to continue

More from MedShots Daily

Cetoleic Acid: A Novel Fish Oil Component for LDL-Cholesterol Reduction?
Cetoleic Acid: A Novel Fish Oil Component for LDL-Cholesterol Reduction?

Recent trial data shows 8 weeks of cetoleic acid supplementation reduces LDL-cholesterol by 7% in overweight adults, offering a new tool for lipid managemen...

2 weeks back

Read More
Full Text
Current Status of Treg Therapy in Transplantation and Autoimmune Disease
Current Status of Treg Therapy in Transplantation and Autoimmune Disease

Explore how Regulatory T cell (Treg) therapy is revolutionizing treatments for transplantation and autoimmune diseases through innovative clinical applicati...

Today

Read More
Full Text
Monitoring Rubella Immunity and Transmission in Central India: Progress Toward the 2026 Goal
Monitoring Rubella Immunity and Transmission in Central India: Progress Toward the 2026 Goal

A study in central India assesses rubella immunity and transmission, highlighting progress and remaining gaps ahead of the 2026 elimination target....

Today

Read More
Full Text
Preoperative Anemia and Iron Deficiency in Cardiac Surgery: Diagnosis and Impact
Preoperative Anemia and Iron Deficiency in Cardiac Surgery: Diagnosis and Impact

A summary of the Inter-American Society of Cardiology position statement on diagnosing preoperative anemia and iron deficiency in cardiac surgery patients....

Today

Read More
Full Text
Direction-Specific Balance Training for Chronic Ankle Instability in Athletes
Direction-Specific Balance Training for Chronic Ankle Instability in Athletes

A meta-analysis reveals that balance training significantly improves direction-specific dynamic balance in athletes with chronic ankle instability (CAI)....

Today

Read More
Full Text
Phase 2b Trial Results: CBL-514 Injection for Abdominal Fat Reduction
Phase 2b Trial Results: CBL-514 Injection for Abdominal Fat Reduction

Results of the Phase 2b trial show CBL-514 injection effectively reduces abdominal subcutaneous fat through adipocyte apoptosis with high patient satisfacti...

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris